Adaptogens vs mushrooms: what's the difference, really?
'Adaptogen' and 'functional mushroom' get used as if they're the same word. They're not. Here's what each term actually means, where they overlap, and how to read a label without falling for marketing.
A reader emailed me last month asking why every mushroom-coffee bag in her cupboard called itself “adaptogenic” while the bottle of ashwagandha in her medicine cabinet didn’t mention mushrooms anywhere. She wanted to know whether she was getting the same thing twice, or two different things, or marketing-flavored air.
It is an excellent question, and one of those cases where the answer is genuinely interesting once you know where the words come from. The short version is that these two terms describe overlapping but distinct categories, the overlap is smaller than the packaging suggests, and the vocabulary has drifted enough in the consumer-wellness space that a careful reader can save themselves real money by knowing the difference.
Here is the difference.
The short answer
Adaptogen is a pharmacological classification — a category of plants and fungi with a specific kind of stress-modulating, multi-system biological activity. Functional mushroom is a culinary-and-supplement category referring to mushrooms with documented biological activity of any kind, not just stress modulation.
Some adaptogens are mushrooms. Most adaptogens are not. Some functional mushrooms qualify as adaptogens. Many do not. The overlap is real but partial, and the marketing tendency to collapse the two terms is more about ease of selling than about the underlying science.
If you remember one thing: adaptogen is a what does it do term. Functional mushroom is a what is it term. They answer different questions.
What ‘adaptogen’ actually means
The word was coined in 1947 by Nikolai Lazarev, a Soviet pharmacologist working in the military-research context of the early Cold War. His team was looking for substances that could improve resilience and performance under stress — soldiers, pilots, factory workers. Lazarev defined an adaptogen as a substance that meets three criteria: it must be non-toxic at typical doses, it must produce a non-specific normalization across the body’s stress response (working “up” when needed and “down” when needed rather than driving a single direction), and it must be broadly active across multiple body systems rather than narrowly targeted.
His student Israel Brekhman expanded and refined the framework through the 1960s and 70s, eventually publishing on ginseng, eleuthero (often called Siberian ginseng, though it’s not a true ginseng), rhodiola, schisandra, and several others. The category is, in other words, a Soviet pharmacological tradition that pre-dates the wellness internet by half a century. Its inclusion criteria are stricter than most contemporary marketing uses suggest.
The modern pharmacology literature — represented by reviews like Alexander Panossian’s work in Pharmaceuticals — has updated the framework to focus on what the molecules actually do at the cellular level: modulation of the hypothalamic-pituitary-adrenal axis, action on stress-protein expression, and effects on neuroendocrine signaling. The contemporary academic definition is recognizably descended from Lazarev’s, but with a mechanistic vocabulary that the early Soviet work didn’t have.
The plants that comfortably meet the classical definition include ashwagandha (Withania somnifera), rhodiola (Rhodiola rosea), holy basil (Ocimum tenuiflorum), eleuthero (Eleutherococcus senticosus), schisandra (Schisandra chinensis), and various ginsengs (Panax species). Most of these are roots or whole herbs. None of them is a mushroom.
What ‘functional mushroom’ means
“Functional mushroom” is a much looser term, popularized in the consumer-supplement space over the past two decades. It refers to mushrooms — fungi, technically, though the colloquial term is fine — that have documented biological activity beyond their food value. The category is built around the mushroom’s effect on something a person might care about: cognition, sleep, immunity, exercise tolerance, mood.
The mushrooms typically included are reishi (Ganoderma lucidum), lion’s mane (Hericium erinaceus), cordyceps (most commonly Cordyceps militaris in modern commerce), chaga (Inonotus obliquus), turkey tail (Trametes versicolor), maitake (Grifola frondosa), and shiitake (Lentinula edodes). Different brands include different subsets. The set is not standardized.
What “functional” means in practice is that there is some literature on the mushroom’s bioactive compounds — beta-glucans, triterpenes, ergosterols, hericenones, erinacines — and some clinical research on at least one outcome of consumer interest. The depth of that evidence varies dramatically across the category. Reishi has decades of pharmacological research and a long history of use in East Asian traditional medicine. Lion’s mane has a smaller but growing clinical literature focused on cognitive outcomes. Chaga has interesting in vitro work but very limited human trials. Turkey tail has FDA-approved cancer-adjunct applications in Japan via the PSK extract. The “functional” label flattens these substantial differences into a single shelf category.
This is the category that mushroom-coffee products sit in. When a bag advertises “functional mushrooms,” it is making a categorical claim about what’s inside, not a claim that the mushrooms inside meet any specific pharmacological definition.
Where they overlap, and where they don’t
The clean Venn diagram looks like this. Of the seven commonly-sold functional mushrooms above, two are widely accepted in the academic literature as meeting adaptogen criteria — reishi and cordyceps. Both have multi-system effects (HPA-axis modulation, immune normalization, fatigue resistance) and substantial human-trial backing.
Lion’s mane is on the border. Most pharmacognosy textbooks classify it as a nootropic rather than an adaptogen, because its strongest documented activity is targeted — promotion of nerve growth factor expression — rather than broadly normalizing. The clinical-research base on lion’s mane and cognition is meaningful (the original 2009 Mori study on mild cognitive impairment is the most cited), but the effects are localized to the nervous system rather than the multi-system stress-modulation pattern adaptogens are defined by. You’ll routinely see lion’s mane on adaptogen lists in consumer marketing. That’s an editorial choice rather than a classification finding.
Chaga, turkey tail, maitake, and shiitake are generally not classified as adaptogens. They have immune-modulating effects of various kinds, and several have specific traditional and clinical uses, but they don’t meet the multi-system stress-protective definition that the academic adaptogen category requires.
The flipside is more dramatic. The non-mushroom adaptogens — ashwagandha, rhodiola, holy basil, eleuthero, schisandra, ginseng — represent the bulk of the studied adaptogen evidence base. Walking down that list, you find some of the better-supported herbs in the supplement world. None of them is a mushroom. If you bought every product labeled “adaptogenic” on the shelf of your local health-food store, you would end up with mostly plants and only some mushrooms.
Adaptogens that aren’t mushrooms
Worth knowing by name, because they’re often more useful than the mushroom-coffee a customer is shopping for:
- Ashwagandha (Withania somnifera). Indian root with the strongest cortisol-and-sleep evidence in the modern adaptogen category. Several decent placebo-controlled trials on stress and anxiety outcomes.
- Rhodiola (Rhodiola rosea). Arctic and high-altitude root with the strongest fatigue-and-stress-resistance literature. Studied in shift workers, students, military.
- Holy basil / tulsi (Ocimum tenuiflorum). South Asian herb with a long Ayurvedic history; smaller but growing clinical literature on stress markers and metabolic outcomes.
- Eleuthero (Eleutherococcus senticosus). The original “Siberian ginseng” of Brekhman’s work; not a true ginseng but a Soviet workhorse adaptogen with a long research tradition in Russia and Eastern Europe.
- Schisandra (Schisandra chinensis). Chinese berry historically used for endurance and concentration; growing interest in liver-protective and cognitive endpoints.
- Panax ginseng and American ginseng (Panax species). The most widely studied of the lot, with thousands of papers covering everything from fatigue to glycemic control.
None of these tastes like coffee, none of them brews into a coffee-adjacent drink on its own, and none of them is a mushroom. They are typically sold as extracts, tinctures, capsules, or component ingredients in herbal teas and blends.
Mushrooms that aren’t adaptogens
Useful for the opposite direction — the mushrooms you’ll see in a “functional” product that aren’t doing the stress-modulation work the marketing implies:
- Lion’s mane. Nootropic, neurotrophic effects on nerve growth factor. Useful, well-studied for what it does, but not technically adaptogenic. The research on lion’s mane and anxiety is interesting but the mechanism is neurological rather than HPA-axis normalization.
- Chaga. High in melanin and polyphenols; interesting in vitro antioxidant data but minimal human stress-response literature. Often sold as adaptogenic; the evidence base for that specific claim is thin.
- Turkey tail. Strong immune-modulating activity (PSK extract is approved as a cancer adjunct in Japan), but not classically adaptogenic.
- Maitake and shiitake. Genuinely interesting metabolic and immune effects, food-grade safety, but the adaptogen label generally doesn’t fit.
Reishi and cordyceps remain the two that solidly cross over.
How to read a label with this vocabulary
The practical payoff is that a more carefully labeled product reads differently once you know what the words mean:
- “With adaptogens” should ideally name the specific adaptogenic ingredients (reishi, cordyceps, ashwagandha, rhodiola, etc.) and their doses. A product that just says “adaptogenic blend” without naming the components is asking for trust the label doesn’t earn.
- “Functional mushrooms” should name the species and ideally indicate whether you’re getting fruiting body or mycelium (a real and meaningful difference in beta-glucan content). A bag that lists “mushroom blend” with no species names is a common red flag.
- “Energy and focus” should map to specific ingredients with relevant evidence — caffeine for the energy, rhodiola or lion’s mane for the focus claim, ideally at studied doses. A blend that hits buzzwords without naming amounts is selling vibes.
- Dose transparency. The studies behind ashwagandha’s cortisol effects use 300–600 mg of standardized extract per day; rhodiola trials use 200–600 mg. If a “stress blend” product gives 50 mg of either, you’re buying the term, not the dose.
This is also why some mushroom-coffee products are meaningfully better than others, and why an honest review of a category leader is useful even if you don’t buy that specific brand.
Why the distinction is worth keeping
The reason to know the difference isn’t pedantry. It is that the language is currently doing two kinds of work, and most consumers don’t notice. “Adaptogen” carries a halo of Soviet pharmacology and several decades of clinical trial work that is mostly about plants. “Functional mushroom” carries a halo of traditional East Asian medicine and a smaller but real modern research base that is mostly about fungi. Conflating the two lets a product borrow the credibility of both categories without delivering on either.
A consumer who knows that ashwagandha is the most-studied adaptogen for sleep, that reishi is the most-studied mushroom for the same outcome, and that they are not the same molecule will shop differently than a consumer who thinks “adaptogen” and “mushroom” mean roughly the same thing. The first consumer can pick the ingredient that matches the outcome. The second is mostly responding to packaging.
The vocabulary is not going to get cleaner anytime soon — the marketing pressure runs the other way. But once you can read the label with the right glossary in your head, the wellness aisle gets noticeably easier to navigate. There are real ingredients in there. They are not all the same. Knowing the difference is the cheapest upgrade to your supplement shopping you’ll find this year.
Sources & further reading
- Adaptogens — A Review of their History, Biological Activity, and Clinical Benefits — HerbalGram / American Botanical Council
- Effects of adaptogens on the central nervous system and the molecular mechanisms associated with their stress-protective activity — Pharmaceuticals
- Medicinal mushrooms: bioactive compounds, secondary metabolites and their pharmaceutical applications — Antioxidants
- Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment — Phytotherapy Research
- Rhodiola rosea in stress induced fatigue — a double blind, cross-over study — Phytomedicine
Reader conversation (6)
We read every response. Selected reader notes below.
I bought four “adaptogenic” coffee blends in the past year and after reading this I realized none of them name the actual adaptogenic dose. Lots of “adaptogenic mushroom blend” with no species and no milligrams. It’s wild how much this terminology lets brands hide behind.
Genuinely useful framing — the “what does it do” vs “what is it” distinction is going to stick in my head. I have been treating these as synonyms for years.
The note about lion’s mane being a nootropic rather than an adaptogen is interesting. I’ve been taking it for focus and it does seem to help mildly, but I had also assumed it was working on my stress response. Probably explains why I never felt calmer on it, just slightly sharper.
That tracks with the mechanism. The lion’s mane literature is about nerve growth factor and neuroplasticity rather than cortisol or HPA-axis modulation. If you want something for the stress side, ashwagandha or rhodiola is going to fit better — the categories really are doing different work, even when products mash them together.
Worth flagging that Brekhman’s original work on eleuthero is mostly published in Russian and not widely accessible in English translation. The English-language adaptogen literature leans heavily on later Western researchers who built on his framework but didn’t always preserve his stricter inclusion criteria. Part of why the term has drifted in consumer use.
Good point and worth noting. Panossian’s 2010 review in Pharmaceuticals is the most accessible bridge for English readers — he was trained in the Soviet pharmacology tradition and has been the most consistent voice trying to keep the contemporary definition close to the original criteria.
As someone from a household where tulsi tea was a daily thing growing up, it has been strange watching ashwagandha and holy basil get re-imported through the wellness aisle at four times the price. The plants have been there the whole time.
Just bought a mushroom coffee yesterday that listed “lion’s mane, chaga, and adaptogens” as ingredients. After this article I realize that “and adaptogens” is doing a lot of work in that sentence and I have no idea what’s actually in there. Going to return it.
Have something to add? Email us and we may include it in a future update.